Neuer Auftrag Institute

Neuer Auftrag Institute

The Neuer Auftrag Institute was a German multinational company, who operated in 12 countries, making genetic and chemical research, with medicines were destined to hospitals and laboratories. And because of the sprouting of many companies of the same branch, the INA finished their activities in the year of 1998.

Neuer Auftrag Institute's History

Logomark

They was established in the years 70 in Leipzig, Germany, for Dierk Adalricus, and in little time the Institute Neuer Auftrag had initiated the activities in England, United States, Denmark, Austria, Russia and France, following later for Turkey and Egypt. In 1981, they arrived until China, Japan and Australia, and in 1988, it arrived at Brazil. The Institute Neuer Auftrag always worked in right-hander support with governments and laboratories. With the aid of other companies the Institute Neuer Auftrag developed remedies and vaccines that total had been directed to the hospitals and research of governmental bodies. In the start of the decade of 90, competitors had started to appear and a competition for chosen teams brought new employees the company and the company kept its as place. In 1998, she locked up its activities for financial reasons and of competition. Its founder and president, Dierk Adalricus, also disappeared together with its company.

Profitability and Financial Performance

In 1989, the Institute Neuer Auftrag had a profit of 11,8 billion dollar, a fall of 17% in relation to its record in 1988. A significant increase in the profit of the company happens in 1995, 21,7 billion dollar. The increase in the production of vaccines and medicines and thus, its bigger use for laboratories and hospitals and the increase of the prices was one of the responsible factors for this improvement.